Gram-negative bacterial infections
MONDO:0021678Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Also known as: bacterial infection, gram-negative, bacterial infections, gram negative, bacterial infections, gram-negative, bacterial infections, gramme negative, gram negative bacterial infections, gram-negative bacterial infection, gramme negative bacterial infections, infection, gram-negative bacterial
300 clinical trials for this condition and its sub-types, 33 tagged with Gram-negative bacterial infections itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gram-negative bacterial infections
-
Helicobacter pylori infectious disease 115 trials
-
Treponema infectious disease 6 trials · 57 incl. sub-types
4 sub-types
- Syphilis 47 trials · 56 incl. sub-types Sub-types →
- Pinta disease 1 trial
- Syphilitic encephalitis 0 trials
- Syphilitic meningitis 0 trials
-
Chlamydiaceae infections 1 trial · 55 incl. sub-types
1 sub-type
- Chlamydia infectious disease 34 trials · 55 incl. sub-types Sub-types →
-
Bordetellosis 0 trials · 39 incl. sub-types
2 sub-types
- Pertussis 39 trials
- Bordetella parapertussis infectious disease 0 trials
-
Moraxellaceae infectious disease 0 trials · 8 incl. sub-types
1 sub-type
- Acinetobacter infectious disease 8 trials
-
Pneumonia caused by gram negative bacteria 5 trials · 7 incl. sub-types
2 sub-types
- Pneumonia caused by chlamydia 2 trials
- Rickettsial pneumonia 0 trials
-
Rickettsiaceae infectious disease 0 trials · 4 incl. sub-types
3 sub-types
- Typhus 0 trials · 3 incl. sub-types Sub-types →
- Spotted fever 0 trials · 1 incl. sub-types Sub-types →
- Rickettsial pneumonia 0 trials
-
Burkholderia infectious disease 0 trials · 3 incl. sub-types
3 sub-types
- Melioidosis 3 trials
- Cepacia syndrome 0 trials
- Glanders 0 trials
-
Anaplasmataceae infectious disease 0 trials · 2 incl. sub-types
4 sub-types
- Ehrlichiosis 1 trial Sub-types →
- Human granulocytic anaplasmosis 1 trial
- Neorickettsia infectious disease 0 trials
- Sennetsu fever 0 trials
-
Bartonellaceae infectious disease 0 trials · 1 incl. sub-types
1 sub-type
- Bartonellosis 0 trials · 1 incl. sub-types Sub-types →
-
Bacteroidaceae infectious disease 0 trials
1 sub-type
- Bacteroides infectious disease 0 trials
-
Fusobacteriaceae infectious disease 0 trials
1 sub-type
- Fusobacterium infectious disease 0 trials
-
1 sub-type
- Syphilitic meningitis 0 trials
-
Streptobacillus infectious disease 0 trials
1 sub-type
- Streptobacillary rat-bite fever 0 trials
Most studied deeper sub-types
-
One shot, six protections: could a single vaccine replace multiple infant shots?
Vaccine OngoingThis trial tests a new vaccine called LBVD, which combines protection against six diseases: diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib. The study enrolls healthy infants around 6 to 8 weeks old who receive three doses at 6, 10, and 14 weeks of age. Researche…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Whooping cough vaccine safety checked in 2,700 thai moms and babies
Vaccine OngoingThis study reviews medical records of about 2,700 pregnant women in Thailand who received the Pertagen® whooping cough vaccine and their babies. Researchers want to see if the vaccine is linked to any delivery complications or health issues in newborns. The goal is to confirm the…
Sponsor: BioNet-Asia Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
New whooping cough vaccine passes major safety check in thousands of adults
Vaccine OngoingThis large Phase 3 trial is testing the safety of a new recombinant pertussis (whooping cough) vaccine in 2,399 healthy adults aged 18 to 75. Participants receive a single booster dose, and researchers monitor for side effects over 28 days. The goal is to confirm the vaccine is s…
Phase 3 • Sponsor: BioNet-Asia Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
New infant vaccine aims to shield against three serious diseases
Vaccine OngoingThis phase 3 study tests a new vaccine (DTacP) that protects infants from diphtheria, tetanus, and whooping cough. Around 2,900 healthy babies aged 2-3 months will receive the vaccine to check its safety and how well it triggers immunity. The trial compares different schedules an…
Phase 3 • Sponsor: China National Biotec Group Company Limited • Aim: Vaccine
Last updated Jun 26, 2026 17:26 UTC
-
Can a common seed oil boost stomach infection treatment?
Disease control OngoingResearchers test whether adding black seed oil to a vonoprazan-based triple therapy clears Helicobacter pylori infection better than the standard triple therapy alone. The trial enrolls 90 adults with confirmed H. pylori who have not been treated before. Participants receive eith…
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can customizing antibiotics beat stomach bug resistance?
Disease control CancelledThis trial compares three ways to treat Helicobacter pylori, a common stomach infection that can lead to ulcers or cancer. One approach uses genetic testing to pick antibiotics, another uses traditional sensitivity testing, and the third uses a standard fixed combination. The goa…
Phase 4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Battle of the bacteria busters: triple vs quadruple therapy for stomach bug
Disease control By invitation onlyThis study tests two different drug combinations to treat Helicobacter pylori, a stomach bacteria that can cause indigestion. About 66 adults with dyspepsia will receive either a triple therapy (amoxicillin, clarithromycin, esomeprazole) or a quadruple therapy (bismuth, metronida…
Sponsor: Akil Al Islam • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Scrub typhus showdown: which antibiotic works best when resistance is rising?
Disease control OngoingThis study tests three antibiotic regimens for scrub typhus, a bacterial infection spread by mites. Researchers compare 7 days of doxycycline, 3 days of doxycycline, and 3 days of azithromycin in 177 hospitalized patients aged 15 and older. The goal is to see which treatment clea…
Phase 4 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could halting antibiotic distributions end trachoma for good?
Disease control CancelledThis study aimed to see if communities with low levels of trachoma could stop receiving yearly azithromycin treatments without the infection coming back. Researchers planned to compare groups that continued or stopped the medicine over three years. However, the trial was withdraw…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Gut bacteria cocktail aimed at superbug infections – trial pulled before start
Disease control CancelledThis study planned to test a treatment called MET-2, a mix of gut bacteria, to help clear antibiotic-resistant germs from the body after a bloodstream infection. It was designed for adults not in intensive care who had a resistant infection. The trial was withdrawn before enrolli…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a common antibiotic beat syphilis?
Disease control OngoingThis study tests whether the antibiotic linezolid can effectively treat early syphilis in 24 adults. Participants have primary, secondary, or early latent syphilis, and some also have well-controlled HIV. The main goal is to see if linezolid reduces syphilis infection markers in …
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New tetracycline drugs take on superbugs in Real-World trial
Disease control By invitation onlyThis real-world study is testing two neotetracycline drugs, eravacycline and tigecycline, in 300 adults with drug-resistant Gram-negative bacterial infections. Researchers will track how well the drugs clear the infection and monitor for side effects. The goal is to see if these …
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a wood compound boost h. pylori treatment?
Disease control OngoingThis study tests whether adding a natural substance called lignin to the usual antibiotic treatment helps more people get rid of H. pylori infection. About 70 adults with a first-time H. pylori diagnosis will take either lignin or a placebo daily for two weeks, alongside standard…
Phase 3 • Sponsor: Zagazig University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New antibiotic takes on superbug in major hospital study
Disease control OngoingThis study looks at whether the antibiotic cefiderocol can lower death rates in hospitalized adults with a tough, drug-resistant Acinetobacter infection. Researchers will compare patients who got cefiderocol to those who received the best available treatment. The goal is to see w…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can targeted antibiotic rounds wipe out blinding eye disease?
Disease control OngoingThis study tests whether giving antibiotics more often to entire communities can eliminate trachoma, an eye infection that can cause blindness. Over 300,000 people in Ethiopia are taking part. The goal is to see if this intensive approach works better than the current yearly trea…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Swallow a string to test for stomach bug?
Diagnosis OngoingThis study tests a new device called the esophageal string test (EST) to diagnose H. pylori, a stomach bacteria that can cause ulcers and cancer. Participants swallow a capsule with a string inside that collects stomach fluids. Researchers compare the results to standard tests. T…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Rapid syphilis test could speed up diagnosis
Diagnosis OngoingThis study is testing a new rapid blood test for syphilis that gives results from a fingerstick sample during a single clinic visit. About 600 adults attending a community health centre in Winnipeg will take part. Researchers want to see if this quick test is as accurate as stand…
Sponsor: University of Manitoba • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
One shot in pregnancy could shield babies from whooping cough
Prevention OngoingThis phase 3 trial will give a single dose of the dTpa vaccine (Boostrix) to 95 healthy Japanese pregnant women between 27 and 37 weeks of pregnancy. The goal is to see if the vaccine triggers strong immunity in the mothers and passes protective antibodies to their babies at birt…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
A simple breath test after a heart attack could prevent dangerous bleeding
Prevention OngoingThis trial tests whether routinely screening heart attack patients for H. pylori, a common stomach bacteria, can prevent upper gastrointestinal bleeding. The bacteria can cause ulcers that bleed, especially when patients take blood thinners after a heart attack. Researchers will …
Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Could a single pill stop lyme disease before it starts?
Prevention OngoingThis study tests a new pill called TP-05 (lotilaner) to see if it can prevent Lyme disease in healthy adults who are often around ticks. The pill is already used in pets to kill ticks. Researchers will give either a low dose, high dose, or placebo to 700 volunteers and watch for …
Phase 2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
Can a common antibiotic prevent STIs? new study tests two dosing strategies
Prevention OngoingThis study tests whether taking doxycycline before potential exposure to STIs works better than taking it after exposure. 300 men who have sex with men will be randomly assigned to one of two groups and followed for 2 years. The goal is to see which approach better prevents chlam…
Phase 4 • Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Heart Patients' stomach ulcer prevention study pulled before starting
Prevention CancelledThis study was designed to see if treating a common stomach bacteria (H. pylori) along with using a stomach acid drug could prevent ulcers caused by low-dose aspirin. It planned to enroll adults with heart or artery disease who needed long-term aspirin therapy. However, the study…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Free stomach infection test and treatment could prevent cancer in at-risk communities
Prevention OngoingThis study screens 500 adults in South Florida for H. pylori, a stomach infection that can lead to chronic gastritis, ulcers, and gastric cancer. Those who test positive receive free treatment with a three-drug combination (VOQUEZNA® Triple Pak®) for 14 days. The goal is to see i…
Phase 4 • Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
At-Home breath test could help prevent stomach cancer
Prevention OngoingThis study screens people in South Florida for H. pylori, a stomach infection that can lead to chronic gastritis, ulcers, and even stomach cancer. Those who test positive receive treatment, and the study compares at-home breath testing versus in-person retesting to confirm the in…
Phase 4 • Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Mystery infections in healthy people: scientists investigate
Knowledge-focused OngoingThis study looks at HIV-negative people who get opportunistic infections—illnesses that usually only affect those with weak immune systems. Researchers want to find out if these patients have unusual antibodies that block a key immune signal. Up to 224 adults in Thailand and Taiw…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Scientists decode genetic clues linking stomach bug to cancer
Knowledge-focused OngoingThis study looks at genetic changes in people with H. pylori infection or stomach cancer to understand how the infection can lead to cancer. Researchers will analyze tissue samples from 110 adults undergoing endoscopy. The goal is to find early warning signs and possible ways to …
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a booster shot stop whooping cough bacteria in its tracks?
Knowledge-focused OngoingThis study looks at whether a booster dose of the acellular pertussis vaccine (Tdap-IPV) can reduce the amount of whooping cough bacteria in the nose after intentional exposure. Healthy adults who were vaccinated as children will receive either the Tdap-IPV booster or a control v…
Phase 4 • Sponsor: Dimitri Diavatopoulos • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
500 kids tracked daily to unlock secrets of winter viruses
Knowledge-focused OngoingThis study follows 500 children under 18 who tested positive for flu, RSV, or COVID-19. Each child takes a daily nose swab for 14 days to measure how the virus levels change over time. Researchers also check if family members get sick. The goal is to understand when kids are most…
Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Massive U.S. study to see if whooping cough vaccine is safe for pregnant women and babies
Knowledge-focused OngoingThis study is using electronic medical records from about 365,000 pregnant women in the U.S. to check the safety of the Adacel vaccine, which protects against tetanus, diphtheria, and whooping cough. Researchers will compare pregnancy and birth outcomes between women who got the …
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Inside the ICU: new study tracks tough pneumonia cases
Knowledge-focused OngoingThis study follows 100 adults hospitalized in intensive care units with severe pneumonia caused by Mycoplasma or Chlamydia bacteria. Researchers will track how patients are treated, how long they stay in the hospital, and how many survive. They will also check for antibiotic resi…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Lockdowns delayed syphilis diagnoses, study finds
Knowledge-focused OngoingThis study examines how the COVID-19 pandemic affected syphilis cases and their interaction with HIV. Researchers will review medical records of 240 adults diagnosed with syphilis in Italy between 2017 and 2025. The goal is to see if pandemic restrictions led to delayed diagnoses…
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:41 UTC